{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:00:20Z","timestamp":1785337220622,"version":"3.55.0"},"reference-count":71,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Altern Lab Anim"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:p>This paper offers a Bayesian Value-of-Information (VOI) analysis for guiding the development of non-animal testing strategies, balancing information gains from testing with the expected social gains and costs from the adoption of regulatory decisions. Testing is assumed to have value, if, and only if, the information revealed from testing triggers a welfare-improving decision on the use (or non-use) of a substance. As an illustration, our VOI model is applied to a set of five individual non-animal prediction methods used for skin sensitisation hazard assessment, seven battery combinations of these methods, and 236 sequential 2-test and 3-test strategies. Their expected values are quantified and compared to the expected value of the local lymph node assay (LLNA) as the animal method. We find that battery and sequential combinations of non-animal prediction methods reveal a significantly higher expected value than the LLNA. This holds for the entire range of prior beliefs. Furthermore, our results illustrate that the testing strategy with the highest expected value does not necessarily have to follow the order of key events in the sensitisation adverse outcome pathway (AOP).<\/jats:p>","DOI":"10.1177\/026119291604400309","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T04:43:44Z","timestamp":1554785024000},"page":"255-269","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of Non-animal Methods for Assessing Skin Sensitisation Hazard: A Bayesian Value-of-Information Analysis"],"prefix":"10.1177","volume":"44","author":[{"given":"Maria","family":"Leontaridou","sequence":"first","affiliation":[{"name":"Wageningen University, Environmental Economics and Natural Resources Group, Wageningen, The Netherlands"},{"name":"BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Gabbert","sequence":"additional","affiliation":[{"name":"Wageningen University, Environmental Economics and Natural Resources Group, Wageningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekko C.","family":"Van Ierland","sequence":"additional","affiliation":[{"name":"Wageningen University, Environmental Economics and Natural Resources Group, Wageningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Worth","sequence":"additional","affiliation":[{"name":"European Commission, Joint Research Centre, Directorate F \u2014 Health, Consumer and Reference Materials, EURL ECVAM, Ispra, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Landsiedel","sequence":"additional","affiliation":[{"name":"BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"key":"bibr1-026119291604400309","unstructured":"ECHA (2014). The Use of Alternatives to Testing on Animals for the REACH Regulation. Second report under Article 117(3) of the REACH Regulation, 131 pp. Helsinki, Finland: European Chemicals Agency."},{"key":"bibr2-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(01)00173-4"},{"key":"bibr3-026119291604400309","first-page":"11","volume":"66","author":"EC","year":"2003","journal-title":"Official Journal of the European Union"},{"key":"bibr4-026119291604400309","first-page":"1","volume":"396","author":"EC","year":"2006","journal-title":"Official Journal of the European Union"},{"key":"bibr5-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1038\/460208a"},{"key":"bibr6-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2014.10.018"},{"key":"bibr7-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfm064"},{"key":"bibr8-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2005.10.014"},{"key":"bibr9-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2010.03.009"},{"key":"bibr10-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2014.08.002"},{"key":"bibr11-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1787\/9789264229709-en"},{"key":"bibr12-026119291604400309","unstructured":"OECD (2015). OECD Guidelines for the Testing of Chemicals, Test No. 442D: In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method, 20 pp. Paris, France: Organisation for Economic Co-operation and Development."},{"key":"bibr13-026119291604400309","unstructured":"WorthA., BarrosoJ., BremerS., BurtonJ., CasatiS., CoeckeS., CorviR., DesprezB., DumontC., GouliarmouV., GoumenouM., Gr\u00e4pelR., GriesingerC., HalderM., Janusch RoiA., KienzlerA., MadiaF., MunnS., NepelskaM., PainiA., PriceA., PrietoP., RolakiA., Sch\u00e4fferM., TriebeJ., WhelanM., WittwehrC. & ZuangV. (2014). Alternative Methods for Regulatory Toxicology \u2014 A State-of-the-art Review, 461 pp. Brussels, Belgium: European Commission."},{"key":"bibr14-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2012.02.007"},{"key":"bibr15-026119291604400309","doi-asserted-by":"publisher","DOI":"10.14573\/altex.1411011"},{"key":"bibr16-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2014.06.001"},{"key":"bibr17-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2014.04.018"},{"key":"bibr18-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-013-1093-6"},{"key":"bibr19-026119291604400309","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/jat.2869","volume":"33","author":"Jaworska J.","year":"2013","journal-title":"Journal of Applied Toxicology"},{"key":"bibr20-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2015.02.011"},{"key":"bibr21-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2014.09.009"},{"key":"bibr22-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2013.08.011"},{"key":"bibr23-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1080\/10807039.2012.685810"},{"key":"bibr24-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclepro.2005.06.003"},{"key":"bibr25-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2013.06.003"},{"key":"bibr26-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3172"},{"key":"bibr27-026119291604400309","doi-asserted-by":"publisher","DOI":"10.14573\/altex.2011.3.211"},{"key":"bibr28-026119291604400309","doi-asserted-by":"publisher","DOI":"10.14573\/altex.2010.4.231"},{"key":"bibr29-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2014.12.008"},{"key":"bibr30-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2012.06.003"},{"key":"bibr31-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-012-0867-6"},{"key":"bibr32-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1111\/j.0272-4332.2004.00555.x"},{"key":"bibr33-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1111\/j.0272-4332.2004.00464.x"},{"key":"bibr34-026119291604400309","doi-asserted-by":"publisher","DOI":"10.3310\/hta8310"},{"key":"bibr35-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1050(199905)8:3<269::AID-HEC425>3.0.CO;2-D"},{"key":"bibr36-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1111\/j.1477-8947.2010.01300.x"},{"key":"bibr37-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1038\/336631a0"},{"key":"bibr38-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-6102-8"},{"key":"bibr39-026119291604400309","first-page":"89","volume-title":"Progress in Molecular Biology and Translational Science","volume":"112","author":"Wallace A.D.","year":"2012"},{"key":"bibr40-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfi099"},{"key":"bibr41-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1097\/00004424-199506000-00002"},{"key":"bibr42-026119291604400309","unstructured":"VarianH.R., BergstromT.C. & WestJ.E. (2003). Intermediate Microeconomics: Test Item File, 416 pp. New York, NY, USA: W.W. Norton & Co."},{"key":"bibr43-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-37887-4"},{"key":"bibr44-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1979.10"},{"key":"bibr45-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2012.05.013"},{"key":"bibr46-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2010.02.003"},{"key":"bibr47-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1038\/350371a0"},{"key":"bibr48-026119291604400309","first-page":"115","volume":"42","author":"Norlen H.","year":"2014","journal-title":"ATLA"},{"key":"bibr49-026119291604400309","unstructured":"OECD (2012). The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Protein Part 1: Scientific Evidence. Series on Testing and Assessment No. 168, 59 pp. Paris, France: Organisation for Economic Co-operation and Development."},{"key":"bibr50-026119291604400309","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jat.2868","volume":"33","author":"Natsch A.","year":"2013","journal-title":"Journal of Applied Toxicology"},{"key":"bibr51-026119291604400309","unstructured":"OECD (2012). QSAR Toolbox. Available at: http:\/\/www.qsartoolbox.org\/ (Accessed 20.06.16)."},{"key":"bibr52-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000003"},{"key":"bibr53-026119291604400309","first-page":"295","volume":"340","author":"Ennever F.K.","year":"1990","journal-title":"Progress in Clinical & Biological Research"},{"key":"bibr54-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1002\/mc.2940140108"},{"key":"bibr55-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2013.09.006"},{"key":"bibr56-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2494.2007.00364.x"},{"key":"bibr57-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedhc.2006.04.009"},{"key":"bibr58-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12231"},{"key":"bibr59-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-007-0421-y"},{"key":"bibr60-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04964.x"},{"key":"bibr61-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1159\/000248854"},{"key":"bibr62-026119291604400309","unstructured":"ECHA (2014). Stated-preference Study to Examine the Economic Value of Benefits of Avoiding Selected Adverse Human Health Outcomes Due to Exposure to Chemicals in the European Union. Part I: Sensitization & Dose Toxicity, 113 pp. Helsinki, Finland: European Chemicals Agency."},{"key":"bibr63-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1997.tb02435.x"},{"key":"bibr64-026119291604400309","unstructured":"European Commission (undated). Eurostat. Available at: http:\/\/ec.europa.eu\/eurostat (Accessed 20.06.16)."},{"key":"bibr65-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000041"},{"key":"bibr66-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10253.x"},{"key":"bibr67-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2012.02075.x"},{"key":"bibr68-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2012.02834.x"},{"key":"bibr69-026119291604400309","unstructured":"Anon. (2015). Analysis of imports of Kathon. Available at: https:\/\/www.zauba.com\/importanalysis-kathon-report.html (Accessed 21.07.16)."},{"key":"bibr70-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2007.01220.x"},{"key":"bibr71-026119291604400309","doi-asserted-by":"publisher","DOI":"10.1111\/cod.12123"}],"container-title":["Alternatives to Laboratory Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026119291604400309","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026119291604400309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:43:14Z","timestamp":1777380194000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/026119291604400309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1177\/026119291604400309"],"URL":"https:\/\/doi.org\/10.1177\/026119291604400309","relation":{},"ISSN":["0261-1929","2632-3559"],"issn-type":[{"value":"0261-1929","type":"print"},{"value":"2632-3559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}